Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1061 clinical trials
None
Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy With or Without the Use of Coronary Calcium Screening in Preventing Future Major Adverse Cardiac Events

current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, non-fatal myocardial infarction (MI), stroke, or any arterial revascularization among a moderate

  • 0 views
  • 14 Apr, 2021
  • 1 location
None
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)

infarct (MI). The trial aims to assess the role of electrophysiology study (EPS) in guiding implantable cardioverter-defibrillator (ICD) implantation, in patients early following MI (first 40 days). The

  • 123 views
  • 18 Oct, 2021
  • 37 locations
None
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy

Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious

  • 0 views
  • 07 Oct, 2021
  • 1 location
None
Tiny Cargo Big Deal! An ED-Based Study of Child Passenger Safety Behaviors

This study involves an emergency department (ED)-based intervention utilizing Motivational Interviewing (MI) techniques and patient-centered eHealth materials (e.g., a tailored, mobile-friendly

  • 0 views
  • 31 Oct, 2021
  • 1 location
None
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

find out if a new cholesterol-lowering injection (inclisiran) safely lowers the risk of heart attacks and strokes in people who have already had one of these conditions, or who have had an operation or

stroke
arterial disease
cardiovascular disease
myocardial infarction
inclisiran
  • 0 views
  • 29 Aug, 2021
  • 1 location
None
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

embolism and mortality. C. Other results include myocardial infarction, pulmonary embolism, transient ischemic attack, hospitalization, drug compliance, quality of life questionnaire (AFEQT), cognitive

  • 0 views
  • 25 Jan, 2021
None
Blood Pressure Control Target in Diabetes

cardiovascular disease (non-fatal stroke, non-fatal myocardial infarction, treated or hospitalized heart failure, and cardiovascular deaths) over a follow-up period of up to 5 years among patients with a history

  • 0 views
  • 08 Oct, 2021
  • 1 location
None
#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support

This project seeks to test the efficacy of a brief eHealth intervention in an international randomized controlled trial (RCT) to increase COVID-19 knowledge and protective behaviors, and reduce psychological distress among LGBT people. This project involves enrolling racially diverse samples of lesbian, gay, bisexual and transgender people in three cities, …

  • 0 views
  • 26 Jul, 2021
  • 3 locations
None
Effectiveness of Repeated MOTivational InterVention to Reduce Ethanol Intake During prEgnancy

Ethanol exposure during pregnancy is associated with adverse perinatal outcomes resulting in high healthcare costs. Primary care centers whose attends low risk women will be randomized to apply a motivational intervention program to the mothers.

  • 1 views
  • 24 Jan, 2021
  • 3 locations
None
China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome

In summary, the CHILLAS study will be the first multicenter study performed in a Chinese population using a patient-level analysis to compare the effects and safety of intensive statin therapy with that of moderate statin therapy. Therefore, it will determine whether "lower is better", that is, whether LDL cholesterol lowering …

atorvastatin
cardiac event
low density lipoprotein
hmg-coa reductase inhibitor
LDL Cholesterol
  • 0 views
  • 07 Nov, 2020
  • 1 location